Skip to main content
Log in

The Interconversion Kinetics, Equilibrium, and Solubilities of the Lactone and Hydroxyacid Forms of the HMG-CoA Reductase Inhibitor, CI-981

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The pH dependence of the interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981 ([R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(l-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-lH-pyrrole-l-hepatonic acid), are important considerations when chosing and developing one of the forms of these compounds. Over a pH range of 2.1 to 6.0 and at 30°C, the apparent solubility of the sodium salt of CI-981 (i.e., the hydroxyacid form) increases about 60-fold, from 20.4 µg/mL to 1.23 mg/mL, and the profile yields a pK a for the terminal carboxyl group of 4.46. In contrast, over a pH range of 2.3 to 7.7 and also at 30°C, the apparent solubility of the lactone form of CI-981 varies little, and the mean solubility is 1.34 (±0.53) µg/mL. The kinetics of interconversion and the equilibrium between the hydroxyacid and the lactone forms have been studied as a function of pH, buffer concentration, and temperature at a fixed ionic strength (0.5 M) using a stability-indicating HPLC assay. The acid-catalyzed reaction is reversible, whereas the base-catalyzed reaction can be treated as an irreversible reaction. More specifically, at pH <6, an equilibrium favoring the hydroxyacid form is established, whereas at pH >6, the equilibrium reaction is no longer detectable and greatly favors the hydroxyacid form. The rate constant for lactone formation, k 1 is well described by specific acid-catalyzed and spontaneous lactonization pathways, whereas the rate constant for lactone hydrolysis (or hydroxyacid formation), k 2, is well described by specific acid-, water-, and specific base-catalyzed pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. S. M. Grundy. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N. Engl. J. Med. 319:24–32 (1988).

    Google Scholar 

  2. B. D. Roth, D. R. Sliskovic, and B. K. Trivedi. Treatment of hypercholesterolemia. Ann. Rep. Med. Chem. 24:147–156 (1989).

    Google Scholar 

  3. M. K. Shaw, R. S. Newton, D. R. Sliskovic, B. D. Roth, E. Ferguson, and B. R. Krause. Hep-G2 cells and primary rat hepatocytes differ in their response to inhibitors of HMG-CoA reductase. Biochem. Biophys. Res. Commun. 170:726–734 (1990).

    Google Scholar 

  4. B. D. Roth, C. J. Blankley, A. W. Chucholowski, E. Ferguson, M. L. Hoefle, D. F. Ortwine, R. S. Newton, C. S. Sekerke, D. R. Sliskovic, C. D. Stratton, and M. W. Wilson. Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus. J. Med. Chem. 34:357–366 (1991).

    Google Scholar 

  5. K. L. Baumann, D. E. Butler, C. F. Deering, K. E. Mennen, A. Millar, T. N. Nanninga, C. W. Palmer, and B. D. Roth. The convergent synthesis of CI-981, an optically active, highly potent, tissue selective inhibitor of HMG-CoA reductase. Tetrahedron Lett. 33:2283–2284 (1992).

    Google Scholar 

  6. A. J. Repta. Alteration of apparent solubility through complexation. In S. H. Yalkowsky (ed.), Techniques of Solubilization of Drugs, Marcel Dekker, New York, 1981, pp. 135–157.

    Google Scholar 

  7. D. D. Perrin, B. Dempsey, and E. P. Serjeant. pKa Prediction for Organic Acids and Bases, Chapman and Hall, New York, 1981, pp. 7–9.

    Google Scholar 

  8. R. Hershfield and G. L. Schmir. The lactonization of ring-substituted coumarinic acids. Structural effects on the partitioning of tetrahedral intermediates in esterification. J. Am. Chem. Soc. 95:7359–7369 (1973).

    Google Scholar 

  9. E. R. Garrett, B. C. Lippold, and J. B. Mielck, Kinetics and mechanisms of lactonization of coumarinic acids and hydrolysis of coumarins I. J. Pharm. Sci. 60:396–405 (1971).

    Google Scholar 

  10. S. Milstien and L. A. Cohen. Concurrent general-acid and general-base catalysis of esterification. J. Am. Chem. Sco. 92:4377–4382 (1970).

    Google Scholar 

  11. W. J. M. Underberg, R. M. J. Goossen, B. R. Smith, and J. H. Beijnen. Equilibrium kinetics of the new experimental anti-tumour compound SK&F 104864-A in aqueous solution. J. Pharm. Biomed. Anal. 8:681–683 (1990).

    Google Scholar 

  12. J. Fassberg and V. J. Stella. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. Sci. 81:676–684 (1992).

    Google Scholar 

  13. D. R. Storm and D. E. Koshland. Effect of small changes in orientation on reaction rate. J. Am. Chem. Soc. 94:5815–5825 (1972).

    Google Scholar 

  14. E. T. Kaiser and F. J. Kézdy. Hydrolysis of cyclic esters. Prog. Bioorg. Chem. 4:239–267 (1976).

    Google Scholar 

  15. B. Capon and S. P. McManus. Neighboring Group Participation, Vol. 1, Plenum Press, New York, 1976, p. 183.

    Google Scholar 

  16. C. K. Ingold. Structure and Mechanism in Organic Chemistry, 2nd ed., Cornell University Press, Ithaca, NY, 1969, pp. 1129–1131.

    Google Scholar 

  17. D. R. Storm and D. E. Koshland. An indication of the magnitude of orientation factors in esterification. J. Am. Chem. Soc. 94:5805–5814 (1972).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kearney, A.S., Crawford, L.F., Mehta, S.C. et al. The Interconversion Kinetics, Equilibrium, and Solubilities of the Lactone and Hydroxyacid Forms of the HMG-CoA Reductase Inhibitor, CI-981. Pharm Res 10, 1461–1465 (1993). https://doi.org/10.1023/A:1018923325359

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018923325359

Navigation